Intestinal barrier regulates immune responses in the liver via IL-10-producing macrophages.

The gut-liver axis is of clinical importance as a potential therapeutic target in a wide range of liver diseases; however, the mechanisms underlying interactions between microbial products and immune responses in the liver remain unknown. In this study, we demonstrated that IL-10-producing macrophages contribute to immune tolerance in the inflamed liver under intestinal barrier disruption in a murine tandem model of dextran sulfate sodium (DSS) colitis and concanavalin A (Con A) hepatitis. Intestinal barrier disruption protected mice from subsequent liver injury, and the severity of colitis directly affected susceptibility to such injury. The protective effect of DSS-Con A was canceled in gut-sterilized mice, suggesting that gut microbiota play a substantial role in this process. Altered gut microbiota and their metabolites, along with a disrupted intestinal barrier, directly gave rise to immunological permissiveness in the inflamed liver. We identified 1-methylnicotinamide (1-MNA) as a candidate metabolite capable of suppressing liver injury with the potential to induce IL-10-producing macrophages. Consistently, expression of nicotinamide N-methyltransferase, which converts nicotinamide to 1-MNA, was upregulated in the liver of DSS-Con A mice, and this effect was abrogated by gut sterilization. Collectively, our results provide a mechanistic insight into the regulation of immunological balance in the liver via the gut-liver axis.

[1]  M. Hattori,et al.  Commensal Lactobacillus Controls Immune Tolerance during Acute Liver Injury in Mice. , 2017, Cell reports.

[2]  F. Tacke,et al.  Liver macrophages in tissue homeostasis and disease , 2017, Nature Reviews Immunology.

[3]  H. Ebinuma,et al.  Bone marrow-derived macrophages distinct from tissue-resident macrophages play a pivotal role in Concanavalin A-induced murine liver injury via CCR9 axis , 2016, Scientific Reports.

[4]  M. Hattori,et al.  Characterisation of the faecal microbiota in Japanese patients with paediatric-onset primary sclerosing cholangitis , 2016, Gut.

[5]  J. Raes,et al.  Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD , 2016, Gut.

[6]  M. Sternak,et al.  1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. , 2016, International immunopharmacology.

[7]  B. Eksteen.  The Gut-Liver Axis in Primary Sclerosing Cholangitis. , 2016, Clinical Liver Disease.

[8]  Y. Saeys,et al.  Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells , 2016, Nature Communications.

[9]  T. Abe,et al.  Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. , 2015, Journal of the American Society of Nephrology : JASN.

[10]  John M Asara,et al.  Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization , 2015, Nature Medicine.

[11]  D. Brenner,et al.  Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[12]  Liwu Li,et al.  Innate Immune Programing by Endotoxin and Its Pathological Consequences , 2015, Front. Immunol..

[13]  I. Crispe.  Immune tolerance in liver disease , 2014, Hepatology.

[14]  M. Sogin,et al.  The microbiota regulates susceptibility to Fas-mediated acute hepatic injury , 2014, Laboratory Investigation.

[15]  Antonio Grieco,et al.  The Liver May Act as a Firewall Mediating Mutualism Between the Host and Its Gut Commensal Microbiota , 2014, Science Translational Medicine.

[16]  T. Kanai,et al.  Role of Toll-Like Receptors in Immune Activation and Tolerance in the Liver , 2014, Front. Immunol..

[17]  T. Hibi,et al.  Macrophages and Dendritic Cells Emerge in the Liver during Intestinal Inflammation and Predispose the Liver to Inflammation , 2014, PloS one.

[18]  J. Talwalkar,et al.  Role of the Microbiota and Antibiotics in Primary Sclerosing Cholangitis , 2013, BioMed research international.

[19]  Masahira Hattori,et al.  Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome , 2013, Nature.

[20]  T. Hibi,et al.  A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. , 2013, Cell host & microbe.

[21]  F. Glenn,et al.  Primary sclerosing cholangitis. , 2013, Surgery, gynecology & obstetrics.

[22]  Lixin Zhu,et al.  Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: A connection between endogenous alcohol and NASH , 2013, Hepatology.

[23]  T. Hibi,et al.  CCR9+ macrophages are required for acute liver inflammation in mouse models of hepatitis. , 2012, Gastroenterology.

[24]  C. Hofmann,et al.  DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. , 2011, Journal of hepatology.

[25]  A. Rudensky,et al.  Regulatory T cells and Foxp3 , 2011, Immunological reviews.

[26]  Manolito Torralba,et al.  Enteric dysbiosis associated with a mouse model of alcoholic liver disease , 2011, Hepatology.

[27]  Percy A. Knolle,et al.  Antigen-presenting cell function in the tolerogenic liver environment , 2010, Nature Reviews Immunology.

[28]  H. Ogata,et al.  Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis , 2010, European journal of immunology.

[29]  O. Goulet,et al.  [Intestinal microbiota in short bowel syndrome]. , 2010, Gastroenterologie clinique et biologique.

[30]  M. Sternak,et al.  Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse , 2010, Pharmacological reports : PR.

[31]  F. Maltais,et al.  Expression and functional significance of nicotinamide N-methyl transferase in skeletal muscles of patients with chronic obstructive pulmonary disease. , 2010, American journal of respiratory and critical care medicine.

[32]  S. Biswas,et al.  Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.

[33]  I. N. Crispe,et al.  The liver as a lymphoid organ. , 2009, Annual review of immunology.

[34]  Vincenzo Cerundolo,et al.  Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. , 2006, Blood.

[35]  M. Neurath,et al.  A key pathogenic role for the STAT1/T‐bet signaling pathway in T‐cell–mediated liver inflammation , 2003, Hepatology.

[36]  Charles A. Janeway,et al.  IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling , 2002, Cell.

[37]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[38]  C. Rabourdin-Combe,et al.  Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival , 1998, European journal of immunology.

[39]  Y. Iwakura,et al.  Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. , 1997, Journal of immunology.

[40]  R. Weinshilboum,et al.  Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. , 1994, The Journal of biological chemistry.

[41]  A. Wendel,et al.  A T cell-dependent experimental liver injury in mice inducible by concanavalin A. , 1992, The Journal of clinical investigation.

[42]  A. Billiau,et al.  Interferon gamma, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice , 1990, The Journal of experimental medicine.

[43]  R. Binns,et al.  Induction of Immunological Tolerance by Porcine Liver Allografts , 1969, Nature.